Guidelines
Guidelines
ACC/AHA issue chest pain data standards update to 2021 guideline
The data standards are an effort to harmonize the language around chest pain and should be “broadly applicable,” the work group says.
Guidelines
ACC fills gaps on guidance for nonstatin therapies for LDL-C lowering
The new guidance addresses the role of nonstatin therapies for lowering LDL-C, which were not addressed in the 2018 ACC/AHA guideline on...
Guidelines
‘Conservative’ USPSTF primary prevention statin guidance finalized
The new statement invites comparison with the more comprehensive 2018 ACC/AHA-multisociety statin guidelines. A slew of editorials across several...
From the Journals
Updates on treatment/prevention of VTE in cancer patients
“Because patients with cancer have a baseline increased risk of VTE, compared with patients without cancer, the combination of both COVID-19 and...
Guidelines
NAMS affirms value of hormone therapy for menopausal women
Recent research supports individualized care to maximize benefits and minimize risks.
Guidelines
New update focuses on NAFLD in lean people
Lean individuals older than 40 with type 2 diabetes should be screened for NAFLD, urge experts.
From the Journals
New European guidelines ‘drastically’ reduce statin eligibility
“The risk threshold in this new guideline means that almost nobody qualifies for treatment in many countries.”
Guidelines
New AHA checklist: Only one in five adults has optimal heart health
The U.S. population is well below optimal levels of cardiovascular health, according to the first study of the AHA’s new Life’s Essential 8 CV...
Guidelines
ACC/AHA issue clinical lexicon for complications of COVID-19
The document standardizes definitions for cardiovascular and noncardiovascular complications and sets out a framework to capture and better...
Guidelines
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Conference Coverage
Experts elevate new drugs for diabetic kidney disease
A consensus statement from the ADA and KDIGO recommends more aggressive combined use of several newer, and costly, drug classes to slow...